Table 3. Serious ocular adverse events reported in study eyes (year 3) (number of cases (rate per injection)).

Adverse event	All subjects who received pegaptanib sodium 0.3 mg or 1 mg in year 3 n = 422 (no of injections = 3227)
Endophthalmitis	2 (0.06% per injection)
Rhegmatogenous retinal detachment	1 (0.03% per injection)
Traumatic cataract	0 (0.0% per injection)
Vitreous haemorrhage	1 (0.03% per injection)